Pharmacotherapy
Psychiatric Clinics of North America · 2023-06 · 46 (2) · 277-290
DOI: 10.1016/j.psc.2023.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatric Clinics of North America, 2023-06. Verfasst von Anna Feeney und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Clinical Trials Network and Institute, Massachusetts General Hospital, One Bowdoin Square, 9th Floor, Boston, MA 02114, USA…. Hauptthemen laut MEDLINE: Ketamine, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 88 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Clinical Trials Network and Institute, Massachusetts General Hospital, One Bowdoin Square, 9th Floor, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA. Electronic address: feeneya…
- Department of Psychiatry, Clinical Trials Network and Institute, Massachusetts General Hospital, One Bowdoin Square, 9th Floor, Boston, MA 02114, USA; Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Feeney, A., & Papakostas, G. I. (2023). Pharmacotherapy. Psychiatric Clinics of North America, 46(2), 277-290. https://doi.org/10.1016/j.psc.2023.02.003
Vancouver
Feeney A, Papakostas GI. Pharmacotherapy. Psychiatric Clinics of North America. 2023;46(2):277-290. doi:10.1016/j.psc.2023.02.003
BibTeX
@article{Feeney2023,
author = {Feeney, Anna and Papakostas, George I},
title = {Pharmacotherapy},
journal = {Psychiatric Clinics of North America},
year = {2023},
volume = {46},
number = {2},
pages = {277--290},
doi = {10.1016/j.psc.2023.02.003}
}
EUVIMED